BATS BZX Real-Time Price
As of 11:52am ET
| +0.10 / +2.31%|
The 2 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 7.25, with a high estimate of 9.50 and a low estimate of 5.00. The median estimate represents a +64.03% increase from the last price of 4.42.
The current consensus among 6 polled investment analysts is to Hold stock in ZIOPHARM Oncology Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.